IGM Biosciences, Inc. Accumulated Other Comprehensive Income
IGM Biosciences, Inc. had Accumulated Other Comprehensive Income of $8.00 thousand as of 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2025-07-31
- 2025-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $8.00K.
- 2025-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $85.00K.
- 2024-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $159.00K.
- 2024-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $421.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2025-06-30 | $8.00K 10-Q · filed 2025-07-31 |
| 2025-03-31 | $85.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $159.00K 10-Q · filed 2025-07-31 |
| 2024-09-30 | $421.00K 10-Q · filed 2024-11-08 |
| 2024-06-30 | -$195.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | -$128.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $151.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | -$277.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$452.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | -$347.00K 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$701.00K 10-K · filed 2024-03-07 |
| 2022-09-30 | -$775.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$462.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | -$193.00K 10-Q · filed 2022-05-09 |
| 2021-12-31 | -$66.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | -$1.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$2.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $14.00K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $26.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $113.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $296.00K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $205.00K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $43.00K 10-K · filed 2021-03-30 |
| 2019-09-30 | $29.00K 10-Q · filed 2019-11-07 |